We also found that compared to prostate cancer patients with two normal copies of OTUD6A, those with OTUD6A amplification showed higher OTUD6A mRNA expression (P = 0.0285) (Supplementary Fig. 1c). Here, OTUD6A is linked to prostate carcinoma.